| Literature DB >> 22347458 |
Cristina Girardi1, Cristiano De Pittà, Silvia Casara, Gabriele Sales, Gerolamo Lanfranchi, Lucia Celotti, Maddalena Mognato.
Abstract
BACKGROUND: Ionizing radiation (IR) can be extremely harmful for human cells since an improper DNA-damage response (DDR) to IR can contribute to carcinogenesis initiation. Perturbations in DDR pathway can originate from alteration in the functionality of the microRNA-mediated gene regulation, being microRNAs (miRNAs) small noncoding RNA that act as post-transcriptional regulators of gene expression. In this study we gained insight into the role of miRNAs in the regulation of DDR to IR under microgravity, a condition of weightlessness experienced by astronauts during space missions, which could have a synergistic action on cells, increasing the risk of radiation exposure. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2012 PMID: 22347458 PMCID: PMC3276573 DOI: 10.1371/journal.pone.0031293
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Experimental procedure of irradiation and microgravity simulation.
Figure 2Differentially expressed miRNAs in irradiated PBL incubated in 1 g condition.
(A) Number of radio-responsive miRNAs at 4 and 24 h after irradiation with 0.2 and 2Gy of γ-rays. (B) Percentage of dose-responsive miRNAs at the same time points. The expression level of each radio-responsive miRNA is the mean of expression values from six different donors/dose determined by the log2 (irradiated/non-irradiated) PBL. (C) Dendrogram showing radio-responsive miRNAs common to 0.2 and 2Gy of γ-rays, whose expression changed between 4 and 24 h after irradiation. Six different donors were analyzed for each dose, as indicated by the capital letters. The range of expression value is from -3.0 (green, down-regulation) to 3.0 (red, up-regulation). Grey boxes correspond to not available (N/A) fluorescent signal from the microarray platform.
Differentially expressed miRNAs in γ-irradiated versus non-irradiated human PBL.
| 4 h after irradiation | 24 h after irradiation | ||||
| miRNA name | 0.2Gy | 2Gy | miRNA name | 0.2Gy | 2Gy |
| hsa-miR-21* | −0.84 | −0.72 | hsa-miR-1225-5p | 0.44 | 0.60 |
| hsa-miR-34b* | −0.89 | −0.85 | hsa-miR-135a* | 0.48 | 0.67 |
| hsa-miR-210 | 0.53 | 0.46 | hsa-miR-152 | −0.43 | −0.41 |
| hsa-miR-630 | −1.75 | −1.41 | hsa-miR-181a-2* | −0.57 | −0.99 |
| hsa-miR-886-3p | −0.59 | −0.91 | hsa-miR-188-5p | 0.60 | 0.73 |
| hsa-miR-199b-5p | 0.58 | 0.39 | hsa-miR-34a | 1.53 | 1.76 |
| hsa-miR-582-5p | 0.48 | 0.39 | hsa-miR-34b* | 1.02 | 1.66 |
| hsa-miR-378 | −0.71 | −0.46 | hsa-miR-424* | 1.00 | 2.08 |
| hsa-miR-513b | −0.96 | −0.65 | hsa-miR-638 | 0.57 | 0.59 |
| hsa-miR-923 | −0.99 | −0.53 | hsa-miR-663 | 0.46 | 0.99 |
| hsa-let-7e | −0.31 | hsa-miR-765 | 0.63 | 0.71 | |
| hsa-miR-16 | 0.30 | hsa-miR-1226* | 0.76 | ||
| hsa-miR-23a* | 0.17 | hsa-miR-150* | 0.38 | ||
| hsa-miR-34a | −0.64 | hsa-miR-202 | 0.43 | ||
| hsa-miR-145 | 0.75 | hsa-miR-601 | 0.78 | ||
| hsa-miR-181b | 0.30 | hsa-miR-760 | 0.42 | ||
| hsa-miR-196b | 0.55 | hsa-miR-886-3p | −0.60 | ||
| hsa-miR-202 | 0.49 | hsa-miR-100 | −0.50 | ||
| hsa-miR-221 | 0.51 | hsa-miR-101* | −0.37 | ||
| hsa-miR-339-3p | −0.34 | hsa-miR-10a | −0.57 | ||
| hsa-miR-345 | −0.62 | hsa-miR-141 | −0.38 | ||
| hsa-miR-425* | 0.43 | hsa-miR-151-3p | −0.32 | ||
| hsa-miR-450a | 0.52 | hsa-miR-16-2* | −0.66 | ||
| hsa-miR-494 | −0.76 | hsa-miR-17 | −0.22 | ||
| hsa-miR-629* | 0.71 | hsa-miR-181a | −0.31 | ||
| hsa-miR-801 | −0.85 | hsa-miR-18b | −0.35 | ||
| hsa-miR-223 | 0.47 | hsa-miR-196a | −0.91 | ||
| hsa-miR-301a | 0.45 | hsa-miR-196b | −0.51 | ||
| hsa-miR-513a-5p | −1.19 | hsa-miR-19b | −0.25 | ||
| hsa-miR-940 | 0.53 | hsa-miR-200b | −0.24 | ||
| hsa-miR-768-5p | −0.38 | hsa-miR-210 | −0.31 | ||
| hsa-miR-146a | −0.41 | hsa-miR-221* | −0.36 | ||
| hsa-miR-575 | −0.47 | hsa-miR-29b-1* | −0.47 | ||
| hsa-miR-378* | −0.47 | hsa-miR-30d | −0.18 | ||
| hsa-miR-188-5p | −0.59 | hsa-miR-30e* | −0.24 | ||
| hsa-miR-126* | −0.60 | hsa-miR-330-3p | −0.34 | ||
| hsa-miR-335 | −0.35 | ||||
| hsa-miR-345 | 1.16 | ||||
| hsa-miR-363 | 0.99 | ||||
| hsa-miR-371-5p | 0.55 | ||||
| hsa-miR-421 | 0.50 | ||||
| hsa-miR-483-5p | 1.33 | ||||
| hsa-miR-494 | 0.87 | ||||
| hsa-miR-505* | −0.40 | ||||
| hsa-miR-513a-5p | 1.06 | ||||
| hsa-miR-513b | 1.19 | ||||
| hsa-miR-513c | 1.22 | ||||
| hsa-miR-551b | −0.40 | ||||
| hsa-miR-574-5p | 0.97 | ||||
| hsa-miR-630 | 0.96 | ||||
| hsa-miR-769-5p | −0.34 | ||||
| hsa-miR-801 | 0.66 | ||||
| hsa-miR-873 | −0.64 | ||||
| hsa-miR-877* | 0.72 | ||||
| hsa-miR-923 | 0.89 | ||||
| hsa-miR-940 | 0.49 | ||||
| hsa-miR-95 | −0.44 | ||||
| hsa-miR-99a | −0.64 |
Irradiated and non-irradiated PBL of the same donors were incubated in static gravity (1 g) for 4 and 24 h, and miRNA expression profile was analyzed at the end of each incubation time. The expression value of each radio-responsive miRNA is the mean of expression levels calculated as the log2 (irradiated/non-irradiated) PBL from six donors/dose (see Table S1). References of miRNAs differentially expressed in other cell types following the exposure to different stressors are given in parentheses.
Figure 3Effect of modeled microgravity on miRNA expression of irradiated PBL.
Number of differentially expressed miRNAs in PBL irradiated with 0.2 and 2Gy and incubated for 4 and 24 h in MMG and in 1 g condition.
Figure 4miRNA changes in human irradiated PBL incubated 24 h in 1 g and in MMG.
A) The Venn Diagram shows the number of common and exclusively expressed miRNAs as a consequence of only radiation (0.2Gy 1 g, 2Gy 1 g) and radiation with microgravity (0.2Gy MMG, 2Gy MMG). B) miRNAs differentially expressed in PBL incubated 24 h in 1 g or MMG after irradiation with 0.2 and 2Gy. The expression level is given as log 2 (irradiated/non-irradiated) PBL incubated in the indicated gravity condition.
Figure 5The procedure of computational prediction of miRNA targets.
miRNA and gene expression profiles were defined in PBL irradiated with 2Gy versus non-irradiated PBL of the same donors, at the end of 24 h-incubation in 1 g and in MMG. Target prediction was first performed by PITA algorithm, then expression data were integrated to improve the detection of functional correlation between miRNA and mRNA expression profiling.
Figure 6Gene Ontology (GO) analysis of anti-correlated target genes in 2Gy-irradiated PBL incubated 24 h in 1 g or MMG.
Biological processes found enriched from GO analysis are shown. For each functional category is shown the number of genes differentially expressed in the two gravity condition.
Significantly anti-correlated genes involved in the DNA-damage response to IR of human PBL.
| Gene symbol | Gene name | Function | 2Gy 1 g | 2Gy MMG |
| F.C. | F.C. | |||
|
| Ataxia Telangiectasia Mutated | DNA damage signal transduction; cell cycle checkpoint | - - | −1.42 |
|
| BCL2-associated X protein | Apoptosis | 3.40 | 3.22 |
|
| BCL2-binding component 3 (PUMA) | Apoptosis | 5.94 | - - |
|
| Cyclin D2 | Cell cycle progression | −1.81 | −1.59 |
|
| Cyclin G1 | Cell cycle progression/arrest | 2.83 | - - |
|
| Cell division cycle 2 (CDK1) | Cell cycle progression | −1.94 | −2.48 |
|
| Cyclin-dependent kinase inhibitor 1A (p21) | Cell cycle arrest | 3.89 | - - |
|
| Cyclin-dependent kinase inhibitor 2A (p14ARF) | DNA damage sensor; cell cycle arrest; apoptosis | −1.61 | - - |
|
| Damage-specific DNA binding protein 2 (p48) | DNA repair | 4.89 | - - |
|
| Tumor protein p53 inducible protein 8 (PIGs) | Apoptosis p53-dependent | 1.46 | 1.40 |
|
| Growth arrest and DNA-damage-inducible, alpha | Growth arrest; DNA repair; apoptosis | 6.23 | - - |
|
| Growth arrest and DNA-damage-inducible, beta | Growth arrest; apoptosis | - - | −2.54 |
|
| Mdm2 p53 binding protein homolog | Inactivation of tumour protein p53 | 3.75 | 2.86 |
|
| Protein phosphatase 1D magnesium-dependent (Wild type p53-induced phosphatase,Wip1) | DNA damage sensor (phosphorylates H2AX) | 1.49 | - - |
|
| p53-inducible ribonucleotide reductase small subunit (p53R2) | DNA repair | - - | 1.76 |
|
| Sestrin 1 (Sestrins) | Cell cycle arrest | 2.56 | - - |
|
| Thrombospondin 1 (TSP1) | Cell growth | 2.44 | - - |
|
| Tumor necrosis factor receptor superfamily, member 10b (DR5) | Apoptosis | 2.60 | 3.65 |
|
| Tumor protein p53 | Cell cycle arrest; DNA repair; apoptosis | - - | −1.73 |
|
| Tumor protein p53 inducible protein 3 (PIGs) | Apoptosis p53-dependent | 1.72 | - - |
|
| Zinc finger, matrin type 3 (PAG608) | Cell growth; apoptosis p53-dependent | 4.60 | - - |
|
| Apoptosis Enhancing Nuclease | Apoptosis | 5.42 | 4.44 |
| BIRC5 | Baculoviral IAP repeat-containing 5 | Apoptosis | −2.90 | −3.43 |
| CDKN1C | Cyclin-dependent kinase inhibitor 1C (p57) | Cell cycle | 2.11 | 4.22 |
|
| Fanconi anemia, complementation group A | DNA repair | −1.56 | - - |
| FANCF | Fanconi anemia, complementation group F | DNA repair | - - | −1.47 |
| FDXR | Ferrodoxin reductase | DNA damage, apoptosis | 10.20 | - - |
| IER5 | Immediate early response 5 | Apoptosis | 1.86 | - - |
|
| Ligase I | DNA Repair | 0.79 | - - |
| MYC | v-myc myelocytomatosis viral oncogene homolog | Cell growth; apoptosis | −2.48 | −2.88 |
|
| Proliferating cell nuclear antigen | DNA repair | 2.41 | 2.60 |
|
| Pleckstrin homology-like domain, family A, member 3 | Apoptosis | 7.57 | 9.98 |
| STAT5A | Signal transducer and activator of transcription 5A | Apoptosis | - - | −1.52 |
| TNFRSF10D | Tumor necrosis factor receptor superfamily, member 10d | Apoptosis | 1.75 | - - |
|
| TP53 regulated inhibitor of apoptosis 1 | Apoptosis | 2.34 | 2.88 |
|
| Xeroderma pigmentosum, complementation group C | DNA repair | 2.36 | 2.08 |
Significantly anti-correlated genes of DDR pathway in 2Gy PBL incubated for 24 h in 1 g or in MMG. Fold change (F.C.) is the mean of the expression values obtained from the transformed log2 (irradiated/non-irradiated) PBL (see Table S5 and Table S6). Genes in bold belong to p53-pathway; genes in italic belong to the GO category “Response to DNA damage stimulus”.
Figure 7Visualization of functional miRNA-mRNA anti-correlation in the main pathways of DNA-damage response.
Analyses were carried out in 2Gy-irradiated PBL incubated for 24 hours in gravity 1 g or in MMG. Circles represent transcripts and triangles miRNAs; the expression levels of each features are represented as color scale. The lists of significantly miRNA-mRNA anti-correlations are reported in Table S3 and Table S4.
Figure 8Microarray data validation by quantitative real-time PCR (qRT-PCR).
Validation of microarray data by qRT-PCR in irradiated (2Gy) vs. non-irradiated PBL. A) Down-regulated miRNAs (miR-144, miR-598, miR-181a-2*) and mRNAs (ATM, STAT5A); B) Up-regulated miRNAs (miR-34a, miR-424*, miR-27a) and mRNAs (BAX, TNFRSF10B). Values (fold change, dark grey bars) are means ± S.E. of independent experiments performed in quadruplicate on PBL samples from 4–6 different donors. The value “1” of control PBL (light grey bars) is arbitrarly given when no change is observed (***P<0.001; **P<0.01, *P<0.05, t-test).
Figure 9Luciferase reporter assay.
Transient transfection analysis for luciferase expression in A549 cells co-transfected with pre-miRNA precursors (pre-miRNAs) miR-27a, miR-144, miR-424*, or pre-miRNA precursor-Negative Control (pre-control), and reporter constructs containing the 3′UTR of the indicated target genes or synthetic sequence including the perfect miR-27a, miR-144 and miR-424* binding site (sensors). Results are shown as mean ± S.D. of Firefly luciferase activity relative to controls, normalized on Renilla luciferase activity, from 3–4 independent experiments (***P<0.001, **P<0.01, t-test).